Discover Top Posts Tagged with #tuberculosis (tb)

Man Tombstone is wild, what do you mean this man is wandering around dying of Tuberculosis and NOONE ELSE GETS IT?

Also they let that poor man die with both his feet out. Like hey man woah he’s already got tuberculosis and now you’ve condemned him to eternal cold feet too?

#tombstone #val kilmer #doc holliday #tuberculosis (tb)

now that I've finished med school I am even more confused about why my med school made me get two TB skin tests when I enrolled. I couldn't get a quant gold, even though they're just as accurate (more so for people who've had the BCG vaccine - folks in my class who had BCG as kids had to get special permission to get quant golds even though skin tests are notoriously not accurate with a prior BCG vax!) And they made everyone get two, even if the first was negative and you had zero risk factors. It was weird as hell.

I'm doing residency onboarding and they just drew a quant gold along with my vaccine titers when I went to get my drug screen. Fast and easy.

#still don't have TB for the record #even though now I've actually seen patients with it #medicine tag #tuberculosis (tb)

The report comes amid cuts to global aid, which health officials say could lead to a resurgence of TB.

The report comes amid cuts to global aid, which health officials say could lead to a resurgence of TB. Cases of tuberculosis (TB), the world’s deadliest infectious disease, are up nearly 10 per cent year-over-year among children in Europe and Central Asia, according to a new report from international health agencies. The data, which is from 2023, indicates that the European region is still grappling with the spillover effects of the COVID-19 pandemic, according to the report from the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization’s (WHO) Europe team. And it comes as health officials warn that cuts to global aid could lead to a resurgence of TB worldwide. In 2023, more than 172,000 people in the European region either got TB or had a relapse of the disease, similar to levels reported in 2022, the analysis shows. While TB deaths declined, they fell at a much slower rate than before the COVID-19 crisis. That suggests many infected people went undiagnosed and untreated when the pandemic disrupted medical services, and that the consequences are now becoming apparent, the report said. The toll on children also appears to be growing, with about 7,500 TB cases among kids under age 15 in the European region in 2023 – a 9.6 per cent increase from the year before, the report found.

#europe #central asian #tuberculosis (TB)#health

Welcome to the first Euractiv's health newsletter in 2024. Some key files are in store in the coming months for health, with the European He

Vladimir, 60, sat on the edge of his bed in the Chiril Draganiuc Institute of Phthisiopneumology, a medical unit for the Republic of Moldova in the capital Chișinău. He and his two other roommates, Igor, who is 50, and Georgi, who is 26, were diagnosed with tuberculosis (TB) – an infectious disease usually caused by bacteria that attack the lungs. “I got scared,” said Vladimir, asked how he felt when he heard his diagnosis: “How could this have happened?”. He was already familiar with the disease before his diagnosis – Vladimir’s father passed away from tuberculosis after a relapse 40 years ago. But even nowadays, while TB is a preventable and usually curable disease, it was the world’s second leading cause of death from a single infectious agent in 2022, after COVID-19 and caused almost twice as many deaths as HIV/AIDS, WHO Global Tuberculosis report found. Ending the tuberculosis epidemic by reducing incidence by 80% and deaths by 90% before 2030, compared to 2015, is part of the UN Sustainable Development Goals (SDGs). Despite that, the TB incidence rate in the past years has not declined. Instead, it rose by 4% between 2020 and 2022, reversing declines of about 2% per year for most of the past two decades. The Stop TB Partnership, a United Nations-hosted organisation, estimated that while Moldova is close to successfully treating at least 90% of notified people with TB, reaching all infected with TB needs more work as it is less than 60%. The disruptions during the COVID-19 pandemic, multi-drug resistant (MDR) TB, co-infections with HIV and poor living conditions are among the burdens to tackle the disease. “Our challenge in the region is that MDR [multidrug-resistant TB] and the co-infection with TB and HIV is high,” said Dumitru Laticevschi, a former TB doctor from Moldova, who currently leads Global Fund’s programmes in Eastern Europe and Central Asia. Moldova is among the WHO European Region’s 18 high-priority countries for TB control. Vladimir is on a treatment plan that should last six months. He is among 30,000 patients with tuberculosis and non-specific affections of the breathing apparatus that are treated yearly in the institute.

#moldova #tuberculosis (TB)#hiv #coinfections #multi-drug resistant tb #health

A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save milli

Ever since he was a medical student, Dr. Neil Martinson has confronted the horrors of tuberculosis, the world’s oldest and deadliest pandemic. For more than 30 years, patients have streamed into the South African clinics where he has worked — migrant workers, malnourished children and pregnant women with HIV — coughing up blood. Some were so emaciated, he could see their ribs. They’d breathed in the contagious bacteria from a cough on a crowded bus or in the homes of loved ones who didn’t know they had TB. Once infected, their best option was to spend months swallowing pills that often carried terrible side effects. Many died. So, when Martinson joined a call in April 2018, he was anxious for the verdict about a tuberculosis vaccine he’d helped test on hundreds of people. The results blew him away: The shot prevented over half of those infected from getting sick; it was the biggest TB vaccine breakthrough in a century. He hung up, excited, and waited for the next step, a trial that would determine whether the shot was safe and effective enough to sell. Weeks passed. Then months. More than five years after the call, he’s still waiting, because the company that owns the vaccine decided to prioritize far more lucrative business. Pharmaceutical giant GSK pulled back on its global public health work and leaned into serving the world’s most-profitable market, the United States, which CEO Emma Walmsley recently called its “top priority.” As the London-based company turned away from its vaccine for TB, a disease that kills 1.6 million mostly poor people each year, it went all in on a vaccine against shingles, a viral infection that comes with a painful rash. It afflicts mostly older people who, in the U.S., are largely covered by government insurance. Importantly, the shingles vaccine shared a key ingredient with the TB shot, a component that enhanced the effectiveness of both but was in limited supply.

#us #uk #global south #tuberculosis (TB)#tb vaccine development #shingles vaccine #shared ingredient #GSK #formerly glaxosmithkline #capitalism

Learning from the TB pandemic, By Morounfolu Olugbosi

No disease should be tolerated, especially deadly infections like TB and COVID-19. All diseases need to be tackled with new technologies and the outreach needed to make sure they are used appropriately. Being endemic is never good enough. As countries around the world — from Kenya to Canada, South Africa to Sweden — relish the prospect of an unofficial transition of COVID-19 from being pandemic…